Antithrombotic Strategy in Cerebral Venous Thrombosis: Differences Between Neurologist and Hematologist Respondents in a Canadian Survey.
Patterns of practice for management of cerebral venous thrombosis in Canada are unknown. We surveyed Canadian neurologists and hematologists regarding anticoagulation in cerebral venous thrombosis. The response rate was 28%, with 27 neurologists and 20 hematologists responding. We found that choice of first-line initial anticoagulation differed significantly between neurologists and hematologists, with 89% of neurologists favouring unfractionated heparin and hematologists' preference split between unfractionated heparin (50%) and low-molecular-weight heparin (50%). Differences in patterns of practice likely reflect clinical equipoise.
1Djavad Mowafaghian Centre for Brain Health,Division of Neurology,Department of Medicine,University of British Columbia.
Thalia S
TS
Field
2Division de Neurologie,Department de médecine,Universitaire de Quebec,Quebec City,Canada.
Marie-Christine
MC
Camden
1Djavad Mowafaghian Centre for Brain Health,Division of Neurology,Department of Medicine,University of British Columbia.
Sohaila
S
Al-Shimemeri
1Djavad Mowafaghian Centre for Brain Health,Division of Neurology,Department of Medicine,University of British Columbia.
Gary
G
Lui
3Division of Hematology,Department of Medicine,University of British Columbia.
Agnes Y Y
AY
Lee
D002170:Canada; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006306:Health Surveys; D006405:Hematology; D006801:Humans; D008297:Male; D000072141:Neurologists / Q000523:psychology*; D018579:Patient Selection; D020246:Venous Thrombosis / Q000188:drug therapy*
D005343:Fibrinolytic Agents
Anticoagulation; Cerebral Venous Thrombosis; Direct Oral Anticoagulants; Novel Oral Anticoagulants; Treatment; Venous Thromboembolism